TGA Approval

MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe (371881)

ARTG ID

371881

ARTG Name

MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe

Sponsor

Amdipharm Mercury Australia Pty Ltd

ARTG Date

August 10, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Amdipharm Mercury (Australia) Pty Ltd

https://medical-cdn.nocode.com/drug_tga/4a720723ae149b51902409de3d5af888.pdf

https://medical-cdn.nocode.com/drug_tga/7937ab0c882cd986dc74f51bdccc589d.pdf

Ingredient Name

lanreotide acetate

Empowering clinical research with data-driven insights and AI-powered tools.

MYTOLAC lanreotide (as acetate) 60 mg solution for injection pre-filled syringe (371881) - TGA 批准文号 | MedPath